{"entity":{"type":"insider","cik":"0001626595","url":"/insider/0001626595","json_url":"/insider/0001626595.json","name":"CL Alaska, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2014-12-23","last":"2017-07-17","span_basis":"filed_date"},"name_variants":[{"name":"CL Alaska, L.P.","source":"filing","n_filings":4,"first_seen":"2014-12-23","last_seen":"2017-07-17"}],"transactions":[{"id":5157437,"accession":"0000899243-17-018338","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-018338","line_url":"/filing/0000899243-17-018338#line-1","is_derivative":false,"issuer_cik":"0001281933","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001281933","owner_cik":null,"owner_name":"CL Alaska, L.P.; Crestline Management, LP; BRATTON DOUGLAS K; Crestline SI (GP), L.P.; Crestline Investors, Inc.","owner_display_name":"CL Alaska, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000000.0,"shares_display":"8,000,000","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":216000000.0,"total_display":"216,000,000.00","total_whole":"216,000,000","shares_owned_after":9166130.0,"shares_owned_after_display":"9,166,130","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-07-13","filed_date":"2017-07-17","scope":"insider"},{"id":2625321,"accession":"0000899243-16-015213","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-015213","line_url":"/filing/0000899243-16-015213#line-1","is_derivative":false,"issuer_cik":"0001281933","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001281933","owner_cik":null,"owner_name":"Crestline SI (GP), L.P.; BRATTON DOUGLAS K; CL Alaska, L.P.; Crestline Management, LP; Crestline Investors, Inc.","owner_display_name":"Crestline SI (GP), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8600000.0,"shares_display":"8,600,000","price_per_share":39.0,"price_display":"39.00","price_state":"stated","total_value":335400000.0,"total_display":"335,400,000.00","total_whole":"335,400,000","shares_owned_after":17166130.0,"shares_owned_after_display":"17,166,130","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-03-01","filed_date":"2016-03-03","scope":"insider"},{"id":9269301,"accession":"0001209191-14-077894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-077894","line_url":"/filing/0001209191-14-077894#line-1","is_derivative":false,"issuer_cik":"0001536054","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001536054","owner_cik":null,"owner_name":"BRATTON DOUGLAS K; CL Alaska, L.P.; Crestline Investors, Inc.; Crestline Management, LP; Crestline SI (GP), L.P.","owner_display_name":"BRATTON DOUGLAS K","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":15000000.0,"total_display":"15,000,000.00","total_whole":"15,000,000","shares_owned_after":988398.0,"shares_owned_after_display":"988,398","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-23","filed_date":"2014-12-24","scope":"insider"},{"id":6297943,"accession":"0001209191-14-077779","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-077779","line_url":"/filing/0001209191-14-077779#line-1","is_derivative":false,"issuer_cik":"0001281933","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001281933","owner_cik":null,"owner_name":"Crestline Management, LP; Crestline SI (GP), L.P.; BRATTON DOUGLAS K; Crestline Investors, Inc.; CL Alaska, L.P.","owner_display_name":"Crestline Management, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":15625000.0,"total_display":"15,625,000.00","total_whole":"15,625,000","shares_owned_after":988398.0,"shares_owned_after_display":"988,398","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-19","filed_date":"2014-12-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001594864","name":"Juno Therapeutics, Inc.","url":"/issuer/0001594864","role":"Ten percent owner","n_filings":4,"first_seen":"2014-12-23","last_seen":"2017-07-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001626595","retrieved_at":"2026-08-23T21:38:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}